Leqembi injectable available in the US within 3 months of FDA approval?

Reported clinical outcomes of injectable Leqembi in first year post-approval

Stock market response to FDA approval of injectable Leqembi

Phase 4 studies for injectable Leqembi initiated within 6 months post-approval?

FDA approves injectable Leqembi by end of 2024?

Global expansion of injectable Leqembi post-FDA approval

Market response to FDA approval of injectable Leqembi

Injectable Leqembi on U.S. market within 3 months post-approval?

Will uniQure's AMT-130 receive FDA Accelerated Approval by end of 2025?

Will uniQure submit BLA for AMT-130 to FDA by mid-2025?

Will uniQure receive FDA Accelerated Approval for AMT-130 by end of 2025?

Will uniQure submit BLA for AMT-130 by June 30, 2025?

Will FDA grant full approval to afami-cel for synovial sarcoma by December 31, 2024?

Global approval statuses of injectable Leqembi by end of 2025

FDA approval of injectable Leqembi by end of 2024?

Clinical benefits of injectable Leqembi in the first year

Other pharma companies follow Eisai/Biogen by 2025?

Viridian Therapeutics submits BLA for veligrotug by end of 2025?

Veligrotug FDA approval for TED by end of 2026?

Will Sangamo submit BLA for ST-920 by end of 2025?

Will Emergent BioSolutions receive FDA approval for the supplemental Biologics License Application for Ebanga™ by September 30, 2025?

Will Emergent BioSolutions submit a supplemental Biologics License Application for Ebanga™ by December 31, 2024?

What will be the peak stock price of Viridian Therapeutics in Q4 2024?

Will FDA grant full approval to cosibelimab for locally advanced or metastatic CSCC by December 31, 2024?

Significant safety concerns for veligrotug by end of 2025?

VRDN-003 topline data outcome by mid-2026?

Veligrotug market share in TED treatment by end of 2027?

Veligrotug market entry strategy for TED by end of 2026?

What will be the next major regulatory milestone for AMT-130 by end of 2025?

Will AMT-130 show significant improvement in cUHDRS by end of 2024?

What will be the outcome of AMT-130 Phase I/II trials by Q1 2025?

How will uniQure's stock price change after FDA decision on AMT-130?

What will be the outcome of AMT-130 Phase I/II trials by June 30, 2025?

How will uniQure's stock price react following FDA decision on AMT-130?

What will be the FDA's decision on AMT-130 by end of 2025?

Will FDA require additional Phase III trials for AMT-130 before approval?

Will Sangamo announce positive Phase 3 results for ST-920 by end of 2025?

What will be the outcome of Sangamo's BLA for ST-920 by end of 2026?

How many competitors will enter Fabry gene therapy market by end of 2025?

How will Sangamo's stock react within a week of FDA's ST-920 decision?

Will FDA grant Accelerated Approval to ST-920 by end of 2026?

What will be the status of Emergent BioSolutions' commercial readiness for Ebanga™ by December 31, 2024?

Will Emergent BioSolutions complete scale-up process validation for Ebanga™ by March 31, 2025?

What will be the status of Emergent BioSolutions' post-licensure commitments for Ebanga™ by December 31, 2025?

What will be the status of Emergent BioSolutions' technology transfer for Ebanga™ by June 30, 2025?

Will Viridian Therapeutics submit a BLA for VRDN-001 in 2025?

Will VRDN-001 receive FDA approval by the end of 2026?

Will Viridian Therapeutics' stock price increase by more than 50% by the end of 2024?

What percentage of TED patients will achieve complete resolution of diplopia with VRDN-001 by the end of 2025?

What will be the primary outcome of the BLA submission for VRDN-001?

Will FDA grant full approval to adagrasib-cetuximab combination for KRAS G12C-mutated colorectal cancer by December 31, 2024?

Which therapy will achieve $1 billion in sales first by December 31, 2025?

Which company will receive full FDA approval for a therapy first in 2024?

Which will be the next FDA-approved therapy for solid tumors by December 31, 2024?